Keto acid therapy in predialysis chronic kidney disease patients: final consensus.
*Department of Nephrology, Centre Hospitalier Universitaire et Universitea Bordeaux II, Bordeaux, France.†Nephrology Dialysis and Renal Transplantation Unit, University Hospital ‘‘S. Giovanni di Dio e Ruggi d’Aragona’’, Salerno, Italy.‡Department of Nephrology, Hopital Pellegrin, Bordeaux, France.§Aurad-Aquitaine, Gradignan, France.{Nephrology Unit, Department of Internal Medicine, University of Pisa, Pisa, Italy.**Division of Nephrology, Department of Internal Medicine, Istanbul School of Medicine, Istanbul University, Capa, Istanbul, Turkey.††Departement de Nephrologie, H^opital E. Herriot, Lyon Cedex, France.‡‡‘‘Dr. Carol Davila’’ Teaching Hospital of Nephrology, Bucharest, Romania.§§Chinese Society of Nephrology, International Society of Nephrology, and Division of Nephrology, Huashan Hospital, Fudan University,Shanghai, People’s Republic of China.{{Division of Nephrology, Baylor College of Medicine, Houston, Texas.***Department of Nephrology, Institute for Clinical and Experimental Medicine and Institute for Postgradual Education, Prague, CzechRepublic.‡‡‡Dialysis Center No. 9, Health Care Service PLC, Euro Care Hungary, Szekesfehervar, Hungary.§§§The First Afﬁliated Hospital, Sun Yat-Sen University, Guangzhou, People’s Republic of China.FinancialDisclosure:TheauthorsbelongtotheFreseniusKabiKetoanalogueAdvisoryBoardandparticipatedinthe5thInternationalAdvisoryBoardMeeting,Vevey,Switzerland,May29,2010.ConsultancyfeesandtravelgrantswerereceivedfromFreseniusKabi.Thearticleswerepub-lished as part of a supplement sponsored by an unrestricted educational grant from Fresenius Kabi.AddressreprintrequeststoPhilippeChauveau,ServicedeNephrologie,HopitalPellegrin,CHUdeBordeaux,PlaceAmelieRabaLeon,33000,Bordeaux, France.